$Monopar Therapeutics (MNPR.US)$
Monopar Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CHANDLER ROBINSON(19.2%),MICHAEL BROWN(17.1%), etc.

$Monopar Therapeutics (MNPR.US)$ Results for the Third Quarter Ended September 30, 2024 Compared to the Third Quarter Ended September 30, 2023
 
Cash and Net Loss
 
Cash and cash equivalents as of September 30, 2024, were $6.0 million. As noted above, the Company completed a registered public offering on October 30, 2024 that yielded net proceeds to the Company of approximately $17.7 million, after deducting placement agent fees and other estimated offering expenses.
 
Monopar project...

$Monopar Therapeutics (MNPR.US)$ Monopar Therapeutics: Sees Current Funds Sufficient to Continue Operations at Least Into H1 of 2026

$Monopar Therapeutics (MNPR.US)$ You really tryin? Or just teasin? Hehehe

$Monopar Therapeutics (MNPR.US)$
can anyone tell me which stock should I buy to get profit because the onse I've been had they're only giving return of 4 to 5%

$Monopar Therapeutics (MNPR.US)$ selling common stocks. of course!

$ImmunityBio (IBRX.US)$
$Monopar Therapeutics (MNPR.US)$
$Aurora Innovation (AUR.US)$
and $Grindr (GRND.US)$
are also boosting portfolios….
and
and
and
are also doing ok (beyond the obvious $Tesla (TSLA.US)$ , $NVIDIA (NVDA.US)$ and $Strategy (MSTR.US)$ .

$Monopar Therapeutics (MNPR.US)$ keep an here another bounce might come